Department of Anesthesiology, Intensive Care Unit, Fukuyama City Hospital, 5-23-1 Zao-cho, Fukuyama, Hiroshima, 721-8511, Japan.
Department of Anesthesiology and Resuscitology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Sci Rep. 2022 Feb 9;12(1):2185. doi: 10.1038/s41598-022-06106-w.
Delirium is a critical challenge in the intensive care unit (ICU) or high care unit (HCU) setting and is associated with poor outcomes. There is not much literature on how many patients in this setting are assessed for delirium and what tools are used. This study investigated the status of delirium assessment tools of patients in the ICU/HCU. We conducted a multicenter prospective observational study among 20 institutions. Data for patients who were admitted to and discharged from the ICU/HCU during a 1-month study period were collected from each institution using a survey sheet. The primary outcome was the usage rate of delirium assessment tools on an institution- and patient-basis. Secondary outcomes were the delirium prevalence assessed by each institution's assessment tool, comparison of delirium prevalence between delirium assessment tools, delirium prevalence at the end of ICH/HCU stay, and the relationship between potential factors related to delirium and the development of delirium. Result showed that 95% of institutions used the Intensive Care Delirium Screening Checklist (ICDSC) or the Confusion Assessment Method for the ICU (CAM-ICU) to assess delirium in their ICU/HCU, and the remaining one used another assessment scale. The usage rate (at least once during the ICU/HCU stay) of the ICDSC and the CAM-ICU among individual patients were 64.5% and 25.1%, and only 8.2% of enrolled patients were not assessed by any delirium assessment tool. The prevalence of delirium during ICU/HCU stay was 17.9%, and the prevalence of delirium at the end of the ICU/HCU stay was 5.9%. In conclusion, all institutions used delirium assessment tools in the ICU/HCU, and most patients received delirium assessment. The prevalence of delirium was 17.9%, and two-thirds of patients had recovered at discharge from ICU/HCU.Trial registration number: UMIN000037834.
谵妄是重症监护病房(ICU)或高护理病房(HCU)环境中的一个重大挑战,与不良预后相关。关于在这种环境下有多少患者接受谵妄评估以及使用了哪些工具,相关文献并不多。本研究调查了 ICU/HCU 患者谵妄评估工具的使用情况。我们在 20 个机构中开展了一项多中心前瞻性观察性研究。每个机构使用调查表格收集了在为期 1 个月的研究期间入住和出院的 ICU/HCU 患者的数据。主要结局是以机构和患者为基础的谵妄评估工具使用率。次要结局是每个机构评估工具评估的谵妄患病率、不同评估工具之间的谵妄患病率比较、ICU/HCU 住院结束时的谵妄患病率,以及与谵妄相关的潜在因素与谵妄发生之间的关系。结果显示,95%的机构在 ICU/HCU 中使用了重症监护谵妄筛查检查表(ICDSC)或 ICU 意识模糊评估法(CAM-ICU)来评估谵妄,还有一个机构使用了另一种评估量表。个体患者中 ICDSC 和 CAM-ICU 的使用率(在 ICU/HCU 住院期间至少使用一次)分别为 64.5%和 25.1%,只有 8.2%的入组患者未使用任何谵妄评估工具进行评估。ICU/HCU 住院期间谵妄的患病率为 17.9%,ICU/HCU 结束时谵妄的患病率为 5.9%。总之,所有机构都在 ICU/HCU 中使用了谵妄评估工具,大多数患者都接受了谵妄评估。谵妄的患病率为 17.9%,三分之二的患者在离开 ICU/HCU 时已康复。试验注册号:UMIN000037834。